XTX Topco Ltd acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 29,885 shares of the company's stock, valued at approximately $693,000.
Other large investors have also made changes to their positions in the company. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health in the fourth quarter valued at about $26,000. UMB Bank n.a. lifted its position in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC lifted its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC lifted its position in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares in the last quarter. Finally, Sterling Capital Management LLC increased its holdings in shares of Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after purchasing an additional 2,554 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the company. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Monday. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. lifted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $33.75.
View Our Latest Analysis on Option Care Health
Insider Activity
In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.64% of the company's stock.
Option Care Health Trading Up 1.9 %
NASDAQ OPCH traded up $0.60 during trading hours on Wednesday, hitting $32.14. 176,770 shares of the company were exchanged, compared to its average volume of 1,785,669. The stock has a 50-day moving average price of $33.31 and a 200 day moving average price of $28.68. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $5.28 billion, a PE ratio of 27.01, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
